Local and State Officials Open New Ameritox Processing Facility

Second Laboratory Opens to Support Growth of Nation’s Leader in Pain Medication Monitoring SolutionsSM
June 9, 2010

Baltimore (May 27, 2010) – Ameritox, the U.S. leader in pain medication monitoring solutions, is welcoming state and local officials to the grand opening of its second laboratory facility in Greensboro, North Carolina. Ameritox representatives will be joined by Greensboro Mayor Bill Knight from 10:30 a.m. to noon on June 9, 2010 at a ribbon-cutting ceremony for the new state-of-the-art laboratory operation.

“We are very excited to open our second full-service laboratory and bring new, well paying  jobs to Greensboro, which offers us an abundance of talented and highly-skilled professionals,” said Ancelmo E. Lopes, Chief Executive Officer of Ameritox. “The new facilities increase our processing capacity and allow for continued growth, supporting our commitment to help the nation’s physicians improve patient care and treatment outcomes.”

Ameritox is the nation’s leader in pain medication monitoring, offering both laboratory services and practice management tools to help clinicians coordinate and optimize the care of chronic pain patients. Ameritox offers Rx GuardianSM, the most thorough and personalized lab service available for monitoring patients on chronic opioid therapy..

“Pain medication monitoring enables physicians to make more informed decisions,” said Harry Leider, M.D., Chief Medical Officer of Ameritox. “Monitoring helps to manage the risks and complexities associated with prescribing pain medications. This new laboratory permits us continue to provide the most advanced tools for clinicians to accurately assess and maximize their patients’ treatment.”

The Ameritox administrative and laboratory facilities in Greensboro, when operating at capacity, will employ more than 228 skilled, full-time people performing leading-edge pain monitoring testing on hundreds of thousands of specimens annually. Ameritox also operates a large, full service laboratory in Midland, Texas.

About Ameritox
Ameritox is the nation’s leader in pain medication monitoring solutions, offering specialized laboratory testing and reporting services. Ameritox’s expertise and innovative science provides physicians with insights and support to enhance and optimize the care of chronic pain patients. Ameritox offers Rx GuardianSM, the most thorough and personalized lab service available for monitoring patients on chronic opioid therapy. Medication monitoring helps physicians make more informed clinical decisions and manage the risks and complexities associated with prescribing pain medications. Ameritox is headquartered in Baltimore, MD with laboratory facilities in Midland, TX and Greensboro, NC.

© 2011, Ameritox, Ltd. All rights reserved. AMERITOX, the AMERITOX logos, PAIN MEDICATION MONITORING SOLUTIONS, AMERITOX MEDICATION MONITORING SOLUTIONS, Rx GUARDIAN AUTOREMINDER, Rx GUARDIAN and PROTECT YOUR PATIENTS, PROTECT YOUR PRACTICE, are trademarks of Ameritox. All other trademarks are the claimed trademarks of others.